An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Completed · Phase 2

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent

In brief

The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.

Key facts

Study ID
NCT00065312
Run by
Eli Lilly and Company
Last updated by the study team
2006-07-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.